Lower Risk of One-Year Non-Relapse Mortality, Rapid Engraftment and Better NK Cell Recovery with GvHD Prophylaxis Based in Post-Transplant Cyclophosphamide/Bendamustine in Pediatric Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Ramirez, Oscar [1 ]
Portilla, Carlos Andres [1 ]
Buitrago, Jorge Luis [1 ]
Lopez, Eduardo [2 ]
机构：
[1] Ctr Med Imbanaco, Pediat Bone Marrow Transplantant Unit, Cali, Colombia
[2] Ctr Med Imbanaco, Pediat Infect Dis Dept, Cali, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
352
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
    Pasic, Ivan
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Mattsson, Jonas
    Michelis, Fotios, V
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1377 - 1387
  • [22] Increased risk of non-relapse mortality within one year after autologous stem cell transplant in older adults, with lymphoma.
    Kalaycio, M
    Pohlman, B
    Sobecks, R
    Andresen, S
    Surnmers, K
    Rybicki, L
    Kuckowski, E
    Bolwell, BJ
    BLOOD, 2004, 104 (11) : 361B - 361B
  • [23] Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
    Ivan Pasic
    Jeffrey H. Lipton
    Dennis D. Kim
    Auro Viswabandya
    Rajat Kumar
    Wilson Lam
    Arjun D. Law
    Jonas Mattsson
    Fotios V. Michelis
    Annals of Hematology, 2020, 99 : 1377 - 1387
  • [24] Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
    Mushtaq, Muhammad Umair
    Kasaeian, Amir
    Chaudhary, Sibgha Gull
    Amin, Muhammad Kashif
    Anwar, Iqra
    Alemi, Hediyeh
    Khavandgar, Naghmeh
    Khalid, Muhammad Fareed
    Mcguirk, Matthew
    Abhyankar, Sunil
    Hamadani, Mehdi
    Shahzad, Moazzam
    BLOOD, 2024, 144 : 7379 - 7380
  • [25] Insufficient recovery of thymic function after T-cell depleted allogeneic haematopoietic stem cell transplantation predicts for post-engraftment infections and non-relapse mortality
    Wils, E. -J.
    van der Holt, B.
    Broers, A.
    Gratama, J. W.
    Braakman, E.
    Cornelissen, J. J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S25 - S26
  • [26] A PROGNOSTIC MODEL FOR NON-RELAPSE MORTALITY RISK BASED ON MACHINE LEARNING IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION
    Yang, Jingjing
    Zhang, Xiawei
    Dou, Liping
    Liu, Daihong
    BONE MARROW TRANSPLANTATION, 2024, 59 : 310 - 311
  • [27] Outcomes of T-cell replete hematopoietic cell transplantation from mismatched related or unrelated donors using high dose post-transplant cyclophosphamide based GVHD prophylaxis
    Vydra, Jan
    Markova, Marketa Stastna
    Valkova, Veronika
    Novakova, Ludmila
    Cemusova, Barbora
    Kolar, Michal
    Hricinova, Mariana
    Pytlik, Robert
    Cetkovsky, Petr
    Vitek, Antonin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 566 - 567
  • [28] A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation
    Hirohisa Nakamae
    Takahiko Nakane
    Hiroshi Okamura
    Hideo Koh
    Yasuhiro Nakashima
    Asao Hirose
    Mika Nakamae
    Mitsutaka Nishimoto
    Masatomo Kuno
    Yosuke Makuuchi
    Naonori Harada
    Teruhito Takakuwa
    Masayuki Hino
    International Journal of Hematology, 2022, 115 : 77 - 86
  • [29] Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) With Post-Transplant Cyclophosphamide (PTCy) As Gvhd Prophylaxis In High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Sampol, A.
    Montesinos, P.
    Serrano, D.
    Herrera, P.
    Pascual, M. J.
    Bermudez, A.
    Castilla-Llorente, C.
    Bento, L.
    Champ, D.
    Perez-Corral, A.
    Buces, E.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S270 - S270
  • [30] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) As Gvhd Prophylaxis Is Effective in Haploidentical Peripheral Stem Cell Transplantation and without Increasing Risk of Relapse
    Lin, Ching Chan
    Chen, Tzu Ting
    Lo, Wen Jyi
    Lein, Ming Yu
    Hiseh, Ching Yun
    Lin, Chen Yuan
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Lin, Che Hung
    Yeh, Su-Peng
    BLOOD, 2017, 130
12345